Found 201 results
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Young, L. S., Martinelli, J., and Petrofsky, M., “Exposure to ethanol up-regulates the expression of Mycobacterium avium complex proteins associated with bacterial virulence.”, The Journal of infectious diseases, vol. 168, no. 4, pp. 961-8, 1993.
L. E. Bermudez, “[Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients].”, Revista paulista de medicina, vol. 105, no. 6, pp. 341-6, 1987.
L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., “Isolation of two subpopulations of Mycobacterium avium within human macrophages.”, FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.”, The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
L. E. Bermudez, Petrofsky, M., and Goodman, J., “Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.”, Infection and immunity, vol. 65, no. 9, pp. 3768-73, 1997.
L. E. Bermudez and Yamazaki, Y., “Effects of macrolides and ketolides on mycobacterial infections.”, Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S., “Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.”, The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S., “Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”, The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
L. E. Bermudez, Wu, M., Enkel, H., and Young, L. S., “Naturally occurring antibodies against Mycobacterium avium complex.”, Annals of clinical and laboratory science, vol. 19, no. 6, pp. 435-43, 1989.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., “Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”, Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.
L. E. Bermudez, “Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide.”, Clinical and experimental immunology, vol. 91, no. 2, pp. 277-81, 1993.
L. E. Bermudez, “[Post-antibiotic effect in the treatment of infections in neutropenic patients].”, Revista do Hospital das Clínicas, vol. 41, no. 2, pp. 76-9, 1986.
L. E. Bermudez, Parker, A., and Petrofsky, M., “Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases.”, Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.
L. E. Bermudez, Young, L. S., and Enkel, H., “Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.”, Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., “Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.”, Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S., “Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.
L. E. Bermudez, “Use of liposome preparation to treat mycobacterial infections.”, Immunobiology, vol. 191, no. 4-5, pp. 578-83, 1994.
L. E. Bermudez and Young, L. S., “Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.”, Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., “Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”, Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.
L. E. Bermudez, “Potential role of cytokines in disseminated mycobacterial infections.”, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.
L. E. Bermudez, Wu, M., and Young, L. S., “Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”, The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez and Sangari, F. J., “Mycobacterial invasion of epithelial cells.”, Sub-cellular biochemistry, vol. 33, pp. 231-49, 2000.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., “Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”, The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”, Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.
L. E. Bermudez, Wu, M., and Young, L. S., “Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor.”, Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.

Pages